vimarsana.com

Page 7 - துறை ஆஃப் உயிர் மருத்துவ அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bryan Jason Bergsteedt

Candidate coronavirus vaccines show promising results in early animal testing

Candidate coronavirus vaccines show promising results in early animal testing A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing. The candidate coronavirus vaccines, created by Virginia Tech s University Distinguished Professor X.J. Meng and UVA Health s Professor Steven L. Zeichner, prevented pigs from being becoming ill with a pig coronavirus, porcine epidemic diarrhea virus (PEDV). The researchers have recently published their findings in the Proceedings of the National Academy of Sciences. The candidate vaccine was developed using an innovative vaccine platform targeting a highly conserved genomic region of coronaviruses. The new vaccine platform utilizes a genome-reduced bacteria to express the coronavirus vaccine antigen on its surface. Such a vaccine platform can be manufactured with low cost in existing facilities around the world, which could meet the pandemic demand.

16 April 2021 Coronavirus Charts and News: Blood Clots As Prevalent With Pfizer And Moderna Vaccine As With AstraZeneca s Also Blood Clot Risk Is Six Times Higher If You Get Infected With COVID

16 April 2021 Coronavirus Charts and News: Blood Clots As Prevalent With Pfizer And Moderna Vaccine As With AstraZeneca s Also Blood Clot Risk Is Six Times Higher If You Get Infected With COVID
econintersect.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from econintersect.com Daily Mail and Mail on Sunday newspapers.

CityU researchers identify super-enhancers that stimulate the activity of breast cancer genes

CityU researchers identify super-enhancers that stimulate the activity of breast cancer genes Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with a high fatality rate. Currently, chemotherapy is the major treatment option, but the clinical result is unsatisfactory. A research team led by biologists at City University of Hong Kong (CityU) has identified and characterized a set of specific super-enhancers that stimulate the activity of the related critical cancer genes. The research has also discovered that the deletion of certain specific super-enhancers can reduce tumour cell growth. The latest findings may help discover new effective drug targets for TNBC patients to improve their survival chance.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.